WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Inpatient Multimodal Path to RecOVEry

Not Applicable

Withdrawn

Conditions: Pain
Opioid Use

Interventions: Other: IMPROVE Protocol

First Posted Date: 2017-10-06

Last Posted Date: 2022-04-21

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT03303664

Locations: 🇺🇸
Carolinas Healthcare System - Stanly, Albemarle, North Carolina, United States
🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States
🇺🇸
Carolinas Healthcare System - Pineville, Charlotte, North Carolina, United States

and more 9 locations

Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Phase 4

Terminated

Conditions: Regional Anesthesia Morbidity
Anticoagulants and Bleeding Disorders
Surgery

Interventions: Drug: Enoxaparin

First Posted Date: 2017-09-28

Last Posted Date: 2023-10-05

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 122

Registration Number: NCT03296033

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States

Implementation of Smoking Cessation Within NCI Community Oncology Research Program (NCORP) Sites

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Other: Personnel Training and Coaching Calls

First Posted Date: 2017-09-25

Last Posted Date: 2022-07-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1094

Registration Number: NCT03291587

Locations: 🇺🇸
Augusta University Medical Center, Augusta, Georgia, United States
🇺🇸
Mercy Hospital Joplin, Joplin, Missouri, United States
🇺🇸
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States

and more 46 locations

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Phase 2

Terminated

Conditions: Appendix Cancer

Interventions: Drug: nintedanib

First Posted Date: 2017-09-19

Last Posted Date: 2022-08-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 5

Registration Number: NCT03287947

Locations: 🇺🇸
Levine Cancer Institute, Charlotte, North Carolina, United States

Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery

Phase 4

Completed

Conditions: Catheter-Associated Urinary Tract Infection

Interventions: Drug: Nitrofurantoin 100 MG
Drug: Placebo Oral Tablet

First Posted Date: 2017-09-19

Last Posted Date: 2022-08-09

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 164

Registration Number: NCT03287089

Locations: 🇺🇸
Atrium Health, Charlotte, North Carolina, United States

Using CBPR to Reduce HIV Risk Among Immigrant Latino MSM

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: HOLA

First Posted Date: 2017-09-08

Last Posted Date: 2018-08-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 186

Registration Number: NCT03276338

Mediterranean Diet and the Gut Microbiome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Other: American Diet
Other: Mediterranean-style Diet

First Posted Date: 2017-08-31

Last Posted Date: 2023-03-22

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT03269032

Locations: 🇺🇸
Wake Forest Baptist Heath, Winston-Salem, North Carolina, United States

Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures

Phase 1

Recruiting

Conditions: Urologic Diseases
Urethral Stricture
Urethral Injury
Male Urogenital Diseases

Interventions: Biological: Autologous Engineered Urethral Construct

First Posted Date: 2017-08-23

Last Posted Date: 2024-11-12

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 10

Registration Number: NCT03258658

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Wake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem, North Carolina, United States

Virtual Visits (Utilization of Virtual Care in Postoperative Patients to Improve the Patient Experience)

Not Applicable

Completed

Conditions: Appendectomy, Laparoscopic
Cholecystectomy, Laparoscopic
Cholecystectomy, Robotic

Interventions: Other: Virtual Visit

First Posted Date: 2017-08-23

Last Posted Date: 2022-08-10

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 460

Registration Number: NCT03258177

Locations: 🇺🇸
Atrium Health- Carolinas Medical Center, Charlotte, North Carolina, United States

Eucrisa for Atopic Dermatitis

Phase 1

Active, not recruiting

Conditions: Mild to Moderate Atopic Dermatitis

Interventions: Behavioral: Online Treatment response
Drug: EUCRISA

First Posted Date: 2017-08-16

Last Posted Date: 2024-08-27

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 28

Registration Number: NCT03250663

Locations: 🇺🇸
Wake Forest University Heath Sciences, Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy